Loading... Please wait...

9/2011 Librede Receives Phase I SBIR Funding from the NIH

Posted

Librede has received a Phase I SBIR grant from the National Institute of Health, "Droplet-based artificial membrane technology for high throughput cell-free ion channel screening," to development a new artifical membrane technology.